Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 109.95%17.17K | 91.31%-20.31K | 148.21%27.14K | -8.19%-607.85K | -241.84%-145.17K | 53.87%-172.68K | -51.53%-233.72K | 58.49%-56.29K | 17.39%-561.86K | 188.37%102.35K |
| Net income from continuing operations | -10.95%-149.12K | 82.65%-54.23K | 32.89%-82.17K | 33.06%-833.49K | 60.51%-263.97K | 44.42%-134.4K | -75.15%-312.67K | 21.62%-122.45K | 30.50%-1.25M | -39.37%-668.51K |
| Operating gains losses | 76.40%755 | 4,346.49%11.51K | -40,711.11%-7.31K | -5,393.18%-7.25K | -15,700.00%-7.43K | 391.95%428 | -3,287.50%-271 | 110.98%18 | 91.01%-132 | -100.60%-47 |
| Asset impairment expenditure | ---- | -104.57%-754 | --754 | -93.71%35.16K | -93.68%35.16K | ---16.5K | --16.5K | --0 | -19.65%558.69K | 9,844.99%556.42K |
| Remuneration paid in stock | --0 | ---- | ---- | 90.85%179.4K | --49.3K | -81.03%15.1K | 1,917.54%115K | --0 | -75.93%94K | --0 |
| Change In working capital | 543.76%165.54K | 144.33%23.17K | 75.20%115.87K | -40.20%18.33K | -80.53%41.76K | 82.42%-37.3K | -381.29%-52.27K | 573.61%66.14K | 13.68%30.65K | 113.64%214.48K |
| -Change in receivables | -263.26%-6.31K | 45.66%8.69K | 222.84%4.83K | -25.53%-3.91K | -27.63%-9.81K | 5.49%3.86K | -37.87%5.97K | 54.78%-3.93K | -122.21%-3.11K | -230.40%-7.68K |
| -Change in prepaid assets | 103.67%1.65K | 184.11%12.6K | -45.58%12.88K | -99.23%228 | -82.51%36.49K | 79.88%-44.94K | -176.09%-14.98K | -4.02%23.66K | 348.72%29.54K | 208.97%208.58K |
| -Change in payables and accrued expense | 4,409.59%170.19K | 104.35%1.88K | 111.54%98.16K | 420.88%22.01K | 11.07%15.08K | -49.68%3.77K | -303.78%-43.25K | 855.38%46.4K | -33.53%4.23K | -49.69%13.58K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 109.74%16.81K | 91.47%-19.95K | 148.21%27.14K | -8.19%-607.85K | -241.84%-145.17K | 53.87%-172.68K | -51.53%-233.72K | 58.49%-56.29K | 17.39%-561.86K | 188.37%102.35K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 32.66%-84.03K | 95.73%-8.89K | 23.81%-31.97K | 11.79%-1.11M | -14.89%-731.02K | -19.17%-124.78K | 46.86%-208.37K | 65.27%-41.96K | 57.52%-1.25M | -170.95%-636.3K |
| Net other investing changes | 32.66%-84.03K | 95.73%-8.89K | 23.81%-31.97K | 11.79%-1.11M | -14.89%-731.02K | -19.17%-124.78K | 46.86%-208.37K | 65.27%-41.96K | 57.52%-1.25M | -170.95%-636.3K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 32.66%-84.03K | 95.73%-8.89K | 23.81%-31.97K | 11.79%-1.11M | -14.89%-731.02K | -19.17%-124.78K | 46.86%-208.37K | 65.27%-41.96K | 57.52%-1.25M | -170.95%-636.3K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 226.09%75K | 20,178.44%1.62M | 744.73K | 23K | 854.55K | 0 | 8K | 0 | ||
| Net issuance payments of debt | --50K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | ---- | ---- | --1.67M | --791.75K | --0 | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | 87.50%15K | --15K | --0 | --0 | --0 | --8K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---64.48K | ---62.03K | --23K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 226.09%75K | ---- | ---- | 20,178.44%1.62M | --744.73K | --23K | --854.55K | --0 | --8K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -93.69%26.23K | 50.91%5.07K | -90.26%9.9K | -94.68%101.61K | -77.76%141.36K | -62.69%415.82K | -99.80%3.36K | -94.68%101.61K | -65.54%1.91M | -71.88%635.56K |
| Current changes in cash | 102.84%7.78K | -94.87%21.16K | 95.08%-4.83K | 94.93%-91.72K | 75.38%-131.46K | 42.71%-274.46K | 175.49%412.46K | 60.45%-98.25K | 50.23%-1.81M | -52.27%-533.95K |
| End cash Position | -75.94%34.01K | -93.69%26.23K | 50.91%5.07K | -90.26%9.9K | -90.26%9.9K | -77.76%141.36K | -62.69%415.82K | -99.80%3.36K | -94.68%101.61K | -94.68%101.61K |
| Free cash from | 109.74%16.81K | 91.47%-19.95K | 148.21%27.14K | -8.19%-607.85K | -241.84%-145.17K | 53.87%-172.68K | -51.53%-233.72K | 58.49%-56.29K | 17.39%-561.86K | 188.37%102.35K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.